Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kaori Matsuzaka"'
Autor:
Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Kazuhiro Noguchi, Shizuka Hayashi, Masatoshi Matsuo, Jun Taguchi
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 493-499 (2021)
We present the case of a patient with multiple tyrosine kinase inhibitor (TKI)-refractory chronic phase chronic myeloid leukemia (CP-CML) with a T315I mutation of abl1. Dasatinib, a second-generation TKI, was administered as the initial treatment but
Externí odkaz:
https://doaj.org/article/851412aad01f4fb5ba755eb233d43451
Autor:
Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya, Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Masatoshi Matsuo, Jun Taguchi, Kuniko Abe, Kazuto Shigematsu
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical histo
Externí odkaz:
https://doaj.org/article/439ff71130c943c8a3352fa45a5d1b48
Autor:
Tatsuro Jo, Haruna Shioya, Hiroo Tominaga, Takahiro Sakai, Shizuka Hayashi, Kaori Matsuzaka, Yohei Kaneko, Masatoshi Matsuo, Jun Taguchi
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
This case report is about a patient who suffered from Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia. The blasts were positive for myeloid-lineage markers including CD13 and CD33, as well as B-cell-lineage markers. Minor bcr-abl1
Externí odkaz:
https://doaj.org/article/a6ab89a3230841d184f80b6bced60b23
Autor:
Tatsuro Jo, Yohei Kaneko, Takayuki Oishi, Kaori Matsuzaka, Haruna Shioya, Takahiro Sakai, Hiroo Tomoinaga, Shizuka Hayashi, Masatoshi Matsuo, Jun Taguchi
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 802-806 (2020)
Herein, we present the case of a patient who suffered from adult T-cell leukemia/lymphoma (ATLL) and hepatocellular carcinoma (HCC) after obtaining a sustained virological response following treatment with a direct-acting antiviral (DAA) at different
Externí odkaz:
https://doaj.org/article/01182646ab8541078a955677bcf12aee
Autor:
Masatoshi Matsuo, Kazuhiro Noguchi, Jun Taguchi, Takahiro Sakai, Tatsuro Jo, Shizuka Hayashi, Kaori Matsuzaka
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 1, Pp 493-499 (2021)
Case Reports in Oncology, Vol 14, Iss 1, Pp 493-499 (2021)
We present the case of a patient with multiple tyrosine kinase inhibitor (TKI)-refractory chronic phase chronic myeloid leukemia (CP-CML) with a T315I mutation of abl1. Dasatinib, a second-generation TKI, was administered as the initial treatment but
Autor:
Haruna Shioya, Hiroo Tominaga, Kuniko Abe, Kazuto Shigematsu, Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Yohei Kaneko, Shizuka Hayashi, Jun Taguchi, Masatoshi Matsuo
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical histo
Autor:
Masatoshi Matsuo, Tatsuro Jo, Kuniko Abe, Jun Taguchi, Hiroo Tominaga, Ritsuko Kubota-Koketsu, Yohei Kaneko, Shizuka Hayashi, Kazuto Shigematsu, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya
Publikováno v:
Anticancer Research. 40:5237-5243
Background/aim Adult T-cell leukemia/lymphoma (ATLL) is a relatively refractory CD4-positive peripheral T-cell lymphoma. VCAP-AMP-VECP (mLSG15) is one of the standard chemotherapeutic regimens for patients with aggressive ATLL. Mogamulizumab (moga),
Autor:
Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Haruna Shioya, Takahiro Sakai, Masatoshi Matsuo, Tatsuro Jo, Jun Taguchi, Kaori Matsuzaka
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
This case report is about a patient who suffered from Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia. The blasts were positive for myeloid-lineage markers including CD13 and CD33, as well as B-cell-lineage markers. Minor bcr-abl1
Autor:
Kazuto Shigematsu, Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Takahiro Sakai, Kaori Matsuzaka, Masatoshi Matsuo, Tatsuro Jo, Haruna Shioya, Jun Taguchi
Publikováno v:
Blood. 134:4048-4048
Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare and quite refractory peripheral T-cell lymphoma. The human T-lymphotropic virus type 1 (HTLV-1) retrovirus causes ATLL. Tax protein produced by HTLV-1 has oncogenic activities, and its pep
Autor:
Kaori Matsuzaka, Naoya Yahagi, Hiroaki Okazaki, Yoshinori Takeuchi, Sachiko Okazaki, Junko Oka, Jun-ichi Osuga, Toshio Murase, Nobuhiro Yamada, Michiyo Amemiya-Kudo, Takashi Yamamoto, Hitoshi Shimano
Publikováno v:
The Journal of biological chemistry. 286(32)
Overexpression of sterol regulatory element-binding protein-1c (SREBP-1c) in β cells causes impaired insulin secretion and β cell dysfunction associated with diminished pancreatic duodenal homeodomain transcription factor-1 (PDX-1) expression in vi